Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Jul 11, 2016 in Melanoma | 0 comments

In a nutshell

This study investigated whether a reduced follow-up schedule affects melanoma patient outcomes, detection of recurrences (when the cancer comes back) and follow-up costs. Researchers suggested that reduced follow-up visits, besides reducing significantly hospital costs, did not affect patients’ outcomes and recurrence detection. 

Some background

Guidelines recommend an intense follow-up for patients with melanoma treated with curative intent. These follow-up visits are important for cancer-related anxiety reduction and early detection of recurrences. However, it is known that 75% of the recurrences are detected by the patients themselves. This suggests that fewer follow-up visits may be adequate. 

Methods & findings

This study included 180 patients with early stage melanoma. Patients were divided in two groups. Group A had 4 follow-up visits within the first year and group B had 1 to 3 follow-up visits. Patients were evaluated in terms of cancer-related anxiety, cancer worry and health-related quality of life.

Recurrence rate one year after diagnosis was 8.6% in group A and 8.0% in group B. Of the patients with recurrences, 53.3% were patient-detected. No differences between group A and B were detected in anxiety and cancer worry, recurrences and quality of life. There was a reduction of 45% in cost of melanoma care and clinic visits for group B.

The bottom line

This study determined that the follow-up visits of melanoma patients after treatment could be reduced. 

Published By :

Annals of Surgical Oncology

Date :

May 19, 2016

Original Title :

The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.

click here to get personalized updates